News

Home News

Successful Preclinical Proof-of-Concept

ApexBio has successfully completed a key series of validation studies, confirming the platform's potential and clearing the path toward regulatory development stages.

Sign up for our newsletter to keep you informed of industry news and company updates.

Sign Up for Updates